Oxford Vaccine

• Oxford-AstraZeneca vaccine shows 70% overall efficacy, more work needed: study

  Detailed results from phase 3 trials have been published after scientists were criticized over a lack of information in their initial announcement last month.

  Health

  Dec 8, 2020
  
• Two shots. A waiting period. Why the coronavirus vaccine won’t be a quick fix

  What happens after you get your first COVID-19 shot? Initially, not much, experts say.

  Health

  Nov 24, 2020
  
• Advertisement
• AstraZeneca releases coronavirus vaccine data. Here’s what Canadians should know

  In September, the federal government announced Canada procured 20 million doses of the AstraZeneca-Oxford vaccine.

  Advertisement

  Nov 23, 2020
• Advertisement
• Coronavirus vaccine by Oxford-AstraZeneca produces immune response among adults

  If it works, a vaccine would allow the world to return to some measure of normality after the tumult of the pandemic.

  World

  Oct 26, 2020
• AstraZeneca expects coronavirus vaccine result by year-end if trials resume soon

  The World Health Organization (WHO) has flagged the AstraZeneca vaccine, which is being developed with the University of Oxford, as the most promising for coronavirus.

  World

  Sep 10, 2020
• AstraZeneca pauses COVID-19 vaccine trial after unexplained illness in U.K.

  Oxford University has partnered with AstraZeneca, a British-Swedish multinational pharmaceutical and biopharmaceutical company, to produce 2 billion doses of the vaccine.

  Health

  Sep 8, 2020
• Here’s when experts say Oxford University’s coronavirus vaccine could be ready

  Dr. Adrian Hill, director of the Jenner Institute at Oxford University, said "certainly there'll be a million doses around in September," thanks to a manufacturing "scale-up."

  Health

  Jul 20, 2020